Uptake, distribution, and speciation of selenoamino acids by human cancer cells: X-ray absorption and fluorescence methods.
about
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.Elemental and chemically specific X-ray fluorescence imaging of biological systemsPreserving elemental content in adherent mammalian cells for analysis by synchrotron-based x-ray fluorescence microscopyChemical analysis of single cells.XAS studies of Se speciation in selenite-fed rats.Preparing adherent cells for X-ray fluorescence imaging by chemical fixation.Distribution and speciation of bromine in mammalian tissue and fluids by X-ray fluorescence imaging and X-ray absorption spectroscopy.Metabolism of selenite in human lung cancer cells: X-ray absorption and fluorescence studies.Redox-active selenium compounds--from toxicity and cell death to cancer treatmentComparison of KP1019 and NAMI-A in tumour-mimetic environments.Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems.Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants.Intracellular distribution and stability of a luminescent rhenium(i) tricarbonyl tetrazolato complex using epifluorescence microscopy in conjunction with X-ray fluorescence imaging.Trace Elements in Ovaries: Measurement and Physiology.X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake.Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells.A highly selective near-infrared fluorescent probe for imaging H2Se in living cells and in vivo.XAS and XFM studies of selenium and copper speciation and distribution in the kidneys of selenite-supplemented rats.Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
P2860
Q27932080-254B2C53-95C2-4046-A3E2-D6E5C7919BA3Q28655858-CAE609E3-2461-457D-96F1-D48DD8B9A5D7Q28817896-F6AEAD9D-A24A-43D4-B8B8-2C0A9776E1FDQ30466574-8794FDD6-846F-4978-970D-48F89D533CD9Q34573982-6D745047-E231-4A87-990F-DE0BB283BC34Q35460183-E0E436E1-0FDF-4AA6-BBEC-2EA267CB0AA8Q35559852-82735E4E-D7ED-42E1-B221-29B344583EBCQ35612719-E786DF05-9E0A-4842-A3A6-A5656A51E0ACQ35658137-979BC4C1-3CBF-4219-92E6-8339287C6AEDQ36086603-D91B5722-99B1-4497-9BF3-E42EA26426E9Q37002586-4162AC41-8F06-4911-B4E5-335841E8FBEDQ38411959-4884B8A2-7722-4197-942B-C3EF8C4693F5Q38727966-0E4FBBAA-F808-42C3-850D-A4E68C4C52F3Q38728617-D240ABBA-C5F5-45C7-8341-2C395C048C24Q39110547-54CDDD17-E15F-4A91-B65B-8189CE97592FQ39294174-33938C83-D309-429A-8A68-A8F9E070DC03Q41150059-3FA2CE66-7B91-419C-B9E6-D573BEA9A6B8Q46897420-729B2A67-9DF5-4FF2-AD97-11E7A24FDD27Q52726721-445CEF6C-1ECA-484B-91A5-08AEE16FDEAF
P2860
Uptake, distribution, and speciation of selenoamino acids by human cancer cells: X-ray absorption and fluorescence methods.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Uptake, distribution, and spec ...... tion and fluorescence methods.
@en
Uptake, distribution, and spec ...... tion and fluorescence methods.
@nl
type
label
Uptake, distribution, and spec ...... tion and fluorescence methods.
@en
Uptake, distribution, and spec ...... tion and fluorescence methods.
@nl
prefLabel
Uptake, distribution, and spec ...... tion and fluorescence methods.
@en
Uptake, distribution, and spec ...... tion and fluorescence methods.
@nl
P2093
P50
P356
P1433
P1476
Uptake, distribution, and spec ...... ption and fluorescence methods
@en
P2093
David J Paterson
Jade B Aitken
Lydia A Finney
Martin D de Jonge
P304
P356
10.1021/BI101678A
P407
P577
2011-02-20T00:00:00Z